NFCR Writer David Perry, Author at NFCR - Page 9 of 9

NFCR Writer David Perry

Forty Percent of American Cancer Cases Linked to Weight

In a report published by the U.S. Centers for Disease Control and Prevention, obesity and even being overweight are associated with at least 13 different types of cancer, comprising 40% of all cancer diagnoses. More than 630,000 people in the U.S. are annually diagnosed with a cancer associated with obesity…...

Read more

Lung Cancers Can Differ by Race

According to Clinical Cancer Research, a journal of the American Association for Cancer Research, recently discovered genetic differences in non-small cell lung cancers (NSCLCs) between some African-Americans and European-Americans suggest that there are racial differences in the biology of the disease. These findings could have a clinical impact on personalized…...

Read more

Using Cancer to Fight Cancer

Researchers at the University of Michigan (U-M) devised a process to grow a series of honeycomb-like arrays of tiny, lab-grown cancers that could one day help doctors zero in on individualized treatments for ovarian cancer. The findings are detailed in a study in the journal, Clinical Cancer Research. Led by…...

Read more

Parasite Killer Too Found to be Effective Cancer Treatment Candidate

Researchers have ascertained that the anti-tapeworm drug, nitazoxanide (NTZ), may also hold out hope as a precision therapy for various cancers. Prostate and colon cancer cells contain high amounts of activated beta-catenin, which correlate to treatment-resistant cancer cells and other oncological parameters. In a study of the cancer-abetting potential of…...

Read more

“System Mistrust” Interferes With Post-Surgery Breast Cancer Treatments

BALTIMORE — A study led by a Johns Hopkins Bloomberg School of Public Health researcher indicates nearly one-third of breast cancer surgery patients went against their doctor’s advice, choosing to not begin or complete adjuvant anti-cancer therapy. The primary factor: a general mistrust of the American healthcare system. Adjuvant therapy…...

Read more

Novel Cancer Genes Discovered Via New Statistical Model

LONDON — A new statistical model developed by scientists at the Francis Crick Institute revealed 27 novel genes thought to prevent cancer from forming, in an analysis of over 2000 tumors across 12 human cancer types. The findings could help create new cancer treatments that target these genes, and open…...

Read more

Genetic Marker Can Help Focus Prostate Cancer Therapies

CLEVELAND, OH — Two studies conducted by the Cleveland Clinic revealed how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies. The studies, published in the October 12 issue of JAMA Oncology, suggest that men who inherit this variant would benefit from a personalized…...

Read more

New Compound Targets Metastatic Cancer Cells

​Scientists​ ​at​ ​Bar-Ilan​ ​University​ ​in​ ​Israel​ ​successfully​ ​targeted​ ​and​ ​rendered​ ​inert​ ​the​ ​enzyme that metastatic​ ​cancer​ ​cells​ ​need​ ​to​ ​survive​ ​in​ ​the​ ​body​ ​once​ ​they​ ​have​ ​left​ ​their​ ​host​ ​tumor.​ ​...

Read more